Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:HSCS NYSE:MLSS NYSE:NSPR NASDAQ:PETV On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHSCSHeartSciences$2.74+2.2%$2.14$1.63▼$5.72$8.53M1.787.05 million shs47,756 shsMLSSMilestone Scientific$0.38+7.6%$0.36$0.22▼$0.68$33.78M1.051.13 million shs154,130 shsNSPRInspireMD$0.72+1.1%$0.88$0.63▼$2.93$33.72M0.78172,538 shs159,091 shsPETVPetVivo$0.80$0.80$0.60▼$1.69$30.08M1.2310,796 shs4,659 shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHSCSHeartSciences+2.24%-1.79%+45.74%+31.73%-37.30%MLSSMilestone Scientific+7.58%+11.57%-2.05%+38.82%-44.25%NSPRInspireMD+1.11%+3.00%-7.14%-44.19%-70.37%PETVPetVivo0.00%-3.75%+0.04%+9.22%+6.67%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHSCSHeartSciences$2.74+2.2%$2.14$1.63▼$5.72$8.53M1.787.05 million shs47,756 shsMLSSMilestone Scientific$0.38+7.6%$0.36$0.22▼$0.68$33.78M1.051.13 million shs154,130 shsNSPRInspireMD$0.72+1.1%$0.88$0.63▼$2.93$33.72M0.78172,538 shs159,091 shsPETVPetVivo$0.80$0.80$0.60▼$1.69$30.08M1.2310,796 shs4,659 shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHSCSHeartSciences+2.24%-1.79%+45.74%+31.73%-37.30%MLSSMilestone Scientific+7.58%+11.57%-2.05%+38.82%-44.25%NSPRInspireMD+1.11%+3.00%-7.14%-44.19%-70.37%PETVPetVivo0.00%-3.75%+0.04%+9.22%+6.67%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHSCSHeartSciences 2.00Hold$8.00191.97% UpsideMLSSMilestone Scientific 3.00Buy$1.00161.85% UpsideNSPRInspireMD 3.00Buy$4.50525.00% UpsidePETVPetVivo 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest HSCS, NSPR, PETV, and MLSS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/24/2026HSCSHeartSciences Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)5/5/2026NSPRInspireMD Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$4.00 ➝ $3.005/4/2026NSPRInspireMD Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$4.00(Data available from 7/11/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHSCSHeartSciencesN/AN/AN/AN/A$0.18 per shareN/AMLSSMilestone Scientific$8.90M3.79N/AN/A$0.11 per share3.47NSPRInspireMD$10.85M3.11N/AN/A$1.83 per share0.39PETVPetVivo$1.05M28.75N/AN/A($0.03) per share-26.67Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHSCSHeartSciences-$8.77M-$4.94N/AN/AN/AN/A-333.50%-140.18%7/23/2026 (Estimated)MLSSMilestone Scientific-$6.93M-$0.05N/AN/AN/A-52.01%-60.26%-40.23%N/ANSPRInspireMD-$19.92M-$0.73N/AN/AN/A-413.96%-69.42%-57.68%N/APETVPetVivo-$10.95M-$0.38N/AN/AN/A-902.82%-4,813.07%-281.78%8/13/2026 (Estimated)Latest HSCS, NSPR, PETV, and MLSS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/23/2026Q4 2026HSCSHeartSciences-$0.66N/AN/AN/A$0.05 millionN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthHSCSHeartSciencesN/AN/AN/AN/AN/AMLSSMilestone ScientificN/AN/AN/AN/AN/ANSPRInspireMDN/AN/AN/AN/AN/APETVPetVivoN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHSCSHeartSciences0.161.191.04MLSSMilestone ScientificN/A2.851.86NSPRInspireMDN/A6.396.05PETVPetVivo0.020.420.47Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHSCSHeartSciences17.24%MLSSMilestone Scientific5.79%NSPRInspireMD44.78%PETVPetVivo24.55%Insider OwnershipCompanyInsider OwnershipHSCSHeartSciences4.90%MLSSMilestone Scientific9.22%NSPRInspireMD34.06%PETVPetVivo10.84%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHSCSHeartSciences103.18 million3.03 millionNot OptionableMLSSMilestone Scientific3088.45 million58.61 millionOptionableNSPRInspireMD5046.84 million18.33 millionOptionablePETVPetVivo2037.59 million19.06 millionNot OptionableHSCS, NSPR, PETV, and MLSS HeadlinesRecent News About These CompaniesPetVivo Holdings Inc (PETV) Q4 2026 Earnings Call Highlights: Navigating Growth Amidst ChallengesJuly 2, 2026 | finance.yahoo.comPetVivo Holdings, Inc.: PetVivo Reports Financial and Operational Results for Fiscal 2026June 30, 2026 | finanznachrichten.dePetVivo Holdings, Inc. (PETV) Q4 2026 Earnings Call Prepared Remarks TranscriptJune 29, 2026 | seekingalpha.comPetVivo Reports Financial and Operational Results for Fiscal 2026June 29, 2026 | globenewswire.comPETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE YEAR 2026 ENDED MARCH 31, 2026June 25, 2026 | globenewswire.comPetVivo Holdings Announces Transformative Acquisition Of PiezoBioMembrane To Build a Leading Functional Biomaterials PlatformJune 24, 2026 | globenewswire.comPetVivo Holdings, Inc. (PETV) Discusses Spryng Technology Adoption and Commercial Expansion in Veterinary Practice TranscriptJune 16, 2026 | seekingalpha.comPetVivo Holdings, Inc. to Present at the Life Sciences Investor Forum on June 24thJune 16, 2026 | globenewswire.comPetVivo Holdings Selects New to The Street for National T.V. Commercials, the #1 New York City Market, Iconic Outdoor Advertising and Influencer ProgramJune 12, 2026 | finanznachrichten.dePetVivo Holdings (OTCQX:PETV) Selects New to The Street for National T.V. Commercials, the #1 New York City Market, Iconic Outdoor Advertising and Influencer ProgramJune 10, 2026 | dispatch.comPetVivo Holdings, Inc. to Host Virtual Investor EventJune 8, 2026 | globenewswire.comPeer To Peer Network: PTOP's AI Partner Tier 1 AI, Signs Contract With OTCQX:PETV as Enterprise ClientApril 29, 2026 | finanznachrichten.dePTOP’s AI Partner Tier 1 AI, Signs Contract With OTCQX:PETV as Enterprise ClientApril 29, 2026 | usatoday.comPetVivo Holdings, Inc. to Present at the Market Movers Investor SummitApril 21, 2026 | newsfilecorp.comNPETVIVO HOLDINGS, INC. TO EXHIBIT AT THE ACVSMR SYMPOSIUM IN LEXINGTON, KENTUCKYMarch 19, 2026 | cincinnati.comCPetVivo Holdings: Balancing Ambitious Growth with Financial RealityFebruary 23, 2026 | newscase.comNPetVivo Holdings Inc (PETV) Q3 2026 Earnings Call Highlights: Strategic Partnerships and AI ...February 19, 2026 | finance.yahoo.comPetVivo Holdings, Inc.: PetVivo Reports Results for Third Quarter and First Nine Months of Fiscal 2026February 18, 2026 | finanznachrichten.dePetVivo Holdings, Inc. (OTC:PETV) Q3 2026 earnings call transcriptFebruary 18, 2026 | msn.comPetVivo Reports Results for Third Quarter and First Nine Months of Fiscal 2026February 18, 2026 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeHSCS, NSPR, PETV, and MLSS Company DescriptionsHeartSciences NASDAQ:HSCS$2.74 +0.06 (+2.24%) Closing price 07/10/2026 04:00 PM EasternExtended Trading$2.70 -0.05 (-1.64%) As of 07/10/2026 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.Milestone Scientific NYSE:MLSS$0.38 +0.03 (+7.58%) Closing price 07/10/2026 03:59 PM EasternExtended Trading$0.37 -0.01 (-2.07%) As of 07/10/2026 07:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.InspireMD NYSE:NSPR$0.72 +0.01 (+1.11%) Closing price 07/10/2026 04:00 PM EasternExtended Trading$0.74 +0.02 (+2.64%) As of 07/10/2026 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.PetVivo NASDAQ:PETV$0.80 0.00 (0.00%) As of 07/10/2026 03:26 PM EasternPetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/06 - 07/10 Why WD-40 Is Proving Great Businesses Never Go Out of Style Rocket Lab’s Stock Drop Comes With a Bullish Twist Power Struggle: Wolfspeed Sues Navitas Over AI Chips Pushing the Edge: Super Micro Computer Reboots the AI Landscape Micron's $250 Billion Bet Could Reshape the AI Memory Race AeroVironment Flies Under Wall Street’s Radar Toward a $4 Billion Target IQM's Nasdaq Debut Could Change the Quantum Race for D-Wave Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
